← Back to ledger
FundingannouncedOctober 26, 2026

New Jersey approves $60.56 million tax-credit award for Amneal's Piscataway manufacturing expansion

Amneal PharmaceuticalsNJPiscataway

The New Jersey Economic Development Authority announced approval of a $60.56 million, five-year tax-credit award supporting Amneal Pharmaceuticals' planned expansion of eight Piscataway buildings into an integrated manufacturing campus. Amneal plans more than $240 million in eligible capital investment over three years and expects the project to create more than 330 full-time jobs while expanding capacity for transdermal patches, biosimilars, and pharmaceutical injectables.

#pharmaceuticals#domestic manufacturing#New Jersey#tax credit#supply chain

Sources

  1. New Jersey Economic Development Authoritynjeda.gov · 2026-10-26

Related Funding milestones

FundingCompletedOct 22, 2026

NJCC closes $15 million financing for ResinTech's Camden manufacturing expansion

New Jersey Community Capital closed a $15 million New Markets Tax Credit financing transaction supporting a 34,500-square-foot addition to ResinTech's Camden, New Jersey, manufacturing and warehouse campus. The approximately $18.6 million project is expected to retain 259 jobs, create 100 permanent jobs, and support production of water-treatment resins.